The changing cost‐effectiveness of primary HIV prevention: simple calculations of direct effects
Abstract Introduction Over the course of the HIV pandemic, prevention and treatment interventions have reduced HIV incidence, but there is still scope for new prevention tools to further control HIV. Studies of the cost‐effectiveness of HIV prevention tools are often done using detailed, “transmissi...
Saved in:
| Main Authors: | Geoff P. Garnett, Joshua T. Herbeck, Adam Akullian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Journal of the International AIDS Society |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jia2.26494 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pregnancy and contraceptive use among participants of childbearing potential in the HVTN 705 HIV vaccine trial in Southern Africa
by: Pamela Mda, et al.
Published: (2025-06-01) -
[Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-per-Responder Analysis]
by: Paolo Gisondi, et al.
Published: (2025-05-01) -
Investigation of the levels of oxidative stress parameters in HIV and HIV-TB co-infected patients
by: Olufunsho Awodele, et al.
Published: (2011-11-01) -
How plausible is it that PEP would be cost‐effective in sub‐Saharan Africa?
by: Geoffrey Peter Garnett, et al.
Published: (2025-06-01) -
Investigating the needs and barriers
for prevention, control, and treatment of HIV/AIDS in transgender population: a systematic review of literature
by: Heshmatollah Sofimajidpour, et al.
Published: (2024-09-01)